Memantine attenuates the increase in striatal preproenkephalin mRNA expression and development of haloperidol-induced persistent oral dyskinesias in rats-Reference-Cited by-同舟云学术

Memantine attenuates the increase in striatal preproenkephalin mRNA expression and development of haloperidol-induced persistent oral dyskinesias in rats

Published:2003-12 Issue:2 Volume:994 Page:188-192
ISSN:0006-8993
Container-title:Brain Research
language:en
Short-container-title:Brain Research

Author:

Andreassen Ole A.,Waage Jo,Finsen Bente,Jørgensen Hugo A.

Publisher

Elsevier BV

Subject

Developmental Biology,Neurology (clinical),Molecular Biology,General Neuroscience

Reference28 articles.

1. Neurotoxicity associated with neuroleptic-induced oral dyskinesias in rats. Implications for tardive dyskinesia?;Andreassen;Prog. Neurobiol.,2000

2. Inhibition by memantine of the development of persistent oral dyskinesias induced by long-term haloperidol treatment of rats;Andreassen;Br. J. Pharmacol.,1996

3. The relationship between oral dyskinesias produced by long-term haloperidol treatment, the density of striatal preproenkephalin messenger RNA and enkephalin peptide, and the number of striatal neurons expressing preproenkephalin messenger RNA in rats;Andreassen;Neuroscience,1999

4. Oral dyskinesias and morphological changes in rat striatum during long-term haloperidol administration;Andreassen;Psychopharmacology (Berl.),2001

5. Involvement of dopamine D1 and D2 receptors in the regulation of proenkephalin mRNA abundance in the striatum and accumbens of the rat brain;Angulo;J. Neurochem.,1992

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Upregulation of dopamine D3, not D2, receptors correlates with tardive dyskinesia in a primate model;Movement Disorders;2014-05-16

2. The influence of glutamatergic antagonism on motor variability, and comparison to findings in schizophrenia patients;Acta Neuropsychiatrica;2013-02-26

3. Animal Models of Tardive Dyskinesia;International Review of Neurobiology;2011

4. Effects of Amantadine on Tardive Dyskinesia;Clinical Neuropharmacology;2010-11

5. Differential striatal levels of TNF-α, NFκB p65 subunit and dopamine with chronic typical and atypical neuroleptic treatment: Role in orofacial dyskinesia;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2008-08